Recent Analyst Forecasts and Stock Ratings
Zevra Therapeutics, Inc. FAQ's
Zevra Therapeutics, Inc. has been rated by research analysts at Guggenheim, Roth Capital, Maxim Group, JMP Securities, H.C. Wainwright, Canaccord Genuity in the past 90 days.